Giunti Psychometrics Holding SpA (MIL:GPSY) EBIT: € Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:GPSY Giunti Psychometrics Holding SpA MIL:GPSY
13 GF Score
Price €4.50
View Full Analysis

What is Giunti Psychometrics Holding SpA EBIT?

Giunti Psychometrics Holding SpA MIL:GPSY +1.12% 13 EBIT is € Mil as of Dec. 2025. GuruFocus rates MIL:GPSY with a GF Score™ of 13/100.

Giunti Psychometrics Holding SpA's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €3.98 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Giunti Psychometrics Holding SpA's annualized ROC % for the quarter that ended in Dec. 2025 was 13.35%. Giunti Psychometrics Holding SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 247.95%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Giunti Psychometrics Holding SpA  (MIL:GPSY) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Giunti Psychometrics Holding SpA's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=3.704 * ( 1 - 36.99% )/( (13.865 + 21.094)/ 2 )
=2.3338904/17.4795
=13.35 %

where

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=33.248 - 10.013 - ( 9.694 - max(0, 12.949 - 22.319+9.694))
=13.865

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=38.771 - 11.319 - ( 6.358 - max(0, 14.86 - 23.216+6.358))
=21.094

Note: The Operating Income data used here is one times the annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Giunti Psychometrics Holding SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3.982/( ( (0.494 + max(0.184, 0)) + (0.433 + max(2.101, 0)) )/ 2 )
=3.982/( ( 0.678 + 2.534 )/ 2 )
=3.982/1.606
=247.95 %

where Working Capital is:

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.983 + 3.173 + 2.14) - (10.013 + 0 + 2.099)
=0.184

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.305 + 3.051 + 6.104) - (11.319 + 0 + 2.04)
=2.101

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Giunti Psychometrics Holding SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=/61.436
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Giunti Psychometrics Holding SpA EBIT Related Terms

Giunti Psychometrics Holding SpA EBIT Historical Data

* Premium members only.

The historical data trend for Giunti Psychometrics Holding SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Giunti Psychometrics Holding SpA EBIT Chart

Giunti Psychometrics Holding SpA Annual Data
Trend Dec24 Dec25
EBIT
3.55 3.98

Giunti Psychometrics Holding SpA Semi-Annual Data
Dec24 Dec25
EBIT 3.55 3.98

MIL:GPSY vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Giunti Psychometrics Holding SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giunti Psychometrics Holding SpA EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Giunti Psychometrics Holding SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Giunti Psychometrics Holding SpA's EV-to-EBIT falls into.


MIL:GPSY
13GF Score
Giunti Psychometrics Holding SpA MIL:GPSY
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Giunti Psychometrics Holding SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was € Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of € Mil mean?
Giunti Psychometrics Holding SpA (MIL:GPSY) has a EBIT of € Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Giunti Psychometrics Holding SpA.
Is Giunti Psychometrics Holding SpA's EBIT too high?
Giunti Psychometrics Holding SpA's current EBIT is € Mil. Overall, Giunti Psychometrics Holding SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Giunti Psychometrics Holding SpA's EBIT compare to ABT and SYK?
Giunti Psychometrics Holding SpA's EBIT of € Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Giunti Psychometrics Holding SpA. Giunti Psychometrics Holding SpA's current EBIT is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giunti Psychometrics Holding SpA stock overvalued right now?
Giunti Psychometrics Holding SpA (MIL:GPSY) has a current EBIT of € Mil. The current EBIT is € Mil. Giunti Psychometrics Holding SpA's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Giunti Psychometrics Holding SpA (MIL:GPSY), the current EBIT is € Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Giunti Psychometrics Holding SpA Business Description

Address Via Fra Paolo Sarpi 7/A, Firenze, ITA, 50136
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
13GF Score

Get the complete analysis for MIL:GPSY

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.50
Price